neon asked
At the current price, a patient has to spend $55,000 per year on this drug to stay alive. It is not covered by health insurance in poorer countries such as South Korea. It is used to treat chronic myeloid leukaemia (CML) which is one of the myeloproliferative disorders (MPDs). These diseases arise from genetic defects in haematopoietic stem cells. The MPDs are associated with an increased production of mature and immature blood cells, which affects one or all cell lineages. The current price does not reflect the money put into developing this drug, it reflects the necessity of this drug to the pateint in order to stay alive. If the patient stops taking this drug, he or she will die. For more information on this illness, this is the website:
499 answers · 0 comments
Answer this yourself in the app
See how this splits by age, gender, and region in the app.
